Clinical profile & predictors of poor outcome of adult HIV-tuberculosis patients in a tertiary care centre in north india

Indian Journal of Medical Research

Volumn 139, Issue , 2014, Pages 154-160

  Sharma, Surendra K ^a   Soneja, Manish ^a   Prasad, K T ^a   Ranjan, Sanjay ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Acquired immune deficiency syndrome; Clinical profile; Human immunodeficiency virus; Immunosuppression; Tuberculosis

Indexed keywords

COTRIMOXAZOLE; EFAVIRENZ; ETHAMBUTOL PLUS ISONIAZID PLUS PYRAZINAMIDE PLUS RIFAMPICIN; LAMIVUDINE; NEVIRAPINE; STAVUDINE; STREPTOMYCIN; ZIDOVUDINE;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; DEATH; DISEASE CLASSIFICATION; DRUG INTERMITTENT THERAPY; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; RETROSPECTIVE STUDY; SPUTUM SMEAR; TERTIARY HEALTH CARE; TOXIC HEPATITIS; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS; VIRUS LOAD; ACQUIRED IMMUNODEFICIENCY SYNDROME; ADVERSE EFFECTS; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOSUPPRESSIVE TREATMENT; INDIA; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; TERTIARY CARE CENTER; TUBERCULOSIS, PULMONARY; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; HIV; HUMANS; IMMUNOSUPPRESSION; INDIA; MALE; MIDDLE AGED; TERTIARY CARE CENTERS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 84896899925     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Sharma SK, Kadhiravan T, Banga A, Goyal T, Bhatia I, Saha PK. Spectrum of clinical disease in a series of 135 hospitalised HIV-infected patients from north India. BMC Infect Dis 2004; 4: 52.
2. Holmes CB, Losina E, Walensky RP, Yazdanpanah Y, Freedberg KA. Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa. Clin Infect Dis 2003; 36: 652-62.
3. Harries A, Maher D, Graham S. TB/HIV: a clinical manual. 23. nd ed. Geneva: World Health Organization; 2004. WHO/HTM/TB/2004. 329.
4. Sharma SK, Mohan A, Kadhiravan T. HIV-TB co-infection: epidemiology, diagnosis & management. Indian J Med Res 2005; 121: 550-67.
5. World Health Organization. Global tuberculosis control: WHO report. 2011. Geneva: WHO; 2011. p. 9-27.
6. Vijay S, Kumar P, Chauhan LS, Rao SV, Vaidyanathan P. Treatment outcome and mortality at one and half year follow-up of HIV infected TB patients under TB control programme in a district of South India. PLoS One 2011; 6: e21008.
7. Swaminathan S, Deivanayagam CN, Rajasekaran S, Venkatesan P, Padmapriyadarsini C, Menon PA, et al. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy. Natl Med J India 2008; 21: 3-8.
8. Tripathy S, Anand A, Inamdar V, Manoj MM, Khillare KM, Datye AS, et al. Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India. Indian J Med Res 2011; 133: 521-8.
9. WHO. Revised recommendations for the selection and use of HIV antibody tests. Wkly Epidemiol Rec 1997; 72: 81-7.
10. Technical and operational guidelines for tuberculosis control. New Delhi: Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India; 2005.
11. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 3rd ed. Geneva: WHO; 2003. WHO/CDS/TB/2003.313.
12. National AIDS Control Organization (NACO). Antiretroviral therapy guidelines for HIV infected adults and adolescents including post-exposure prophylaxis. New Delhi, India: NACO; 2007. p. 1-125.
13. Arora VK, Kumar SV. Pattern of opportunistic pulmonary infections in HIV sero-positive subjects: observations from Pondicherry, India. Indian J Chest Dis Allied Sci 1999; 41: 135-44.
14. Kumarasamy N, Solomon S, Jayaker Paul SA, Venilla R, Amalraj RE. Spectrum of opportunistic infections among AIDS patients in Tamil Nadu, India. Int J STD AIDS 1995; 6:447-9.
15. Gothi D, Joshi JM. Clinical and laboratory observations of tuberculosis at a Mumbai (India) clinic. Postgrad Med J 2004; 80: 97-100.
16. Sharma SK, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res 2004; 120: 316-53.
17. Chaisson RE, Schecter GF, Theuer CP, Rutherford GW, Echenberg DF, Hopewell PC. Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am Rev Respir Dis 1987; 136: 570-4.
18. Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993; 148: 1292-7.
19. Zumla A, Malon P, Henderson J, Grange JM. Impact of HIV infection on tuberculosis. Postgrad Med J 2000; 76: 259-68.
20. Agarwal U, Kumar A, Behera D. Profile of HIV associated tuberculosis at a tertiary institute in setting of free anti-retroviral therapy. J Assoc Physicians India 2009; 57: 685-90.
21. Sharma SK, Dhooria S, Prasad KT, George N, Ranjan S, Gupta D, et al. Outcomes of antiretroviral therapy in a northern Indian urban clinic. Bull World Health Organ 2010; 88: 222-6.
22. Dheda K, Lampe FC, Johnson MA, Lipman MC. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis 2004; 190: 1670-6.
23. Alpert PL, Munsiff SS, Gourevitch MN, Greenberg B, Klein RS. A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis 1997; 24: 661-8.
24. Sharma SK, Mohan A. Multidrug-resistant tuberculosis. Indian J Med Res 2004; 120: 354-76.